Navigation Links
Spaulding Clinical Research Partners With Verified Clinical Trials Protecting Clinical Trials From Dual Enrollment
Date:4/23/2013

West Bend, Wisconsin, USA (PRWEB) April 23, 2013

Today, Spaulding Clinical Research, a change agent in the clinical research and medical device industries, announces a partnership with Verified Clinical Trials, the world's leader in the field of clinical trial database registries. This partnership demonstrates both companies commitment to improving research volunteer safety, while preserving data integrity in clinical trials.

"A significant number of research volunteers are attempting to dual enroll in clinical trials or are not waiting for the appropriate washout period. With our focus on delivering high-quality data to our study sponsors, we chose Verified Clinical Trials registry as a partner because of their extensive North American network and their scalability,” states Cassandra Erato, Director of Clinical Operations at Spaulding Clinical Research.

Mitchell D. Efros, MD, CEO of Verified Clinical Trials (VCT) states. “This partnership strengthens our network and adds improved quality to the trials conducted not only at Spaulding Clinical Research but at our partner sites across our network. Unfortunately, in just a short period of time we have stopped many participants from breaking the rules, putting both the volunteer and the study at risk."

To learn more about how Verified Clinical Trials and Spaulding Clinical Research’s partnership is making a difference, visit Verified Clinical Trials at Partnerships in Clinical Trials, April 22-24th, in Orlando.

About Spaulding Clinical Research, LLC
Spaulding Clinical Research, LLC (http://www.spauldingclinical.com) a change agent in the clinical research and medical device industries, is focused on driving perpetual value for their clients through technology and process innovation that delivers speed, unprecedented quality and lower costs.

About Verified Clinical Trials
Verified Clinical Trials, (VCT) (http://www.verifiedclinicaltrials.com) the world's leader in the field of clinical trial database registries, proactively improves research subject safety and data quality in clinical research trials by halting dual enrollment in clinical trials. With a web-based solution designed to enhance the quality of both early and late phase trials, VCT has the scalability to reach all sites nationally and globally and is HIPAA- and 21 CFR part 11-compliant.

Spaulding Clinical Media Contact                
Kathy Forde                                
Sr. Director of Marketing                    
Tel: (414) 303-1912                            
Email: kathy.forde(at)spauldingclinical(dot)com

Verified Clinical Trials Media Contact
Kerri Weingard, ANP
Chief Operating Officer
Tel: (516) 998-7499
Email: kweingard(at)verifiedclinicaltrials(dot)com

Read the full story at http://www.prweb.com/releases/VerifiedClinicalTrials/SpauldingClinicalResearch/prweb10659883.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Medrio, a Leading EDC and eClinical SaaS Provider for Clinical Research, Announces the Highly Anticipated Release of Medrio 8.1 with iPad Support
2. The American Society for Clinical Investigation and Doximity Build Interactive Community
3. Translating Preclinical Pharmacology to Clinical Activity with Myriad RBM’s Inflammation MAP
4. Verified Clinical Trials Exhibits at the Annual 2013 Partnerships In Clinical Trials to Discuss the Professional Research Subject and the Clinical Trial Database Registry
5. Infinata’s BioPharm Insight to Offer Exclusive Preview of 2013 Key Reports at the BIO International Conference and Partnerships in Clinical Trials
6. Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories
7. 4th Annual Advancing Global Clinical Trials Conference is Announced
8. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
9. Pre-Clinical Imaging (In vivo) Market - by Systems and Reagents - Competitive Analysis & Global Forecasts to 2017
10. TGen-Scottsdale Healthcare clinical trial results for BIND-014 presented at AACR 2013
11. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 Infectex Ltd., a Russian portfolio ... 2b-3 clinical study of SQ109 added to the standard drug therapy regimen in patients ... scientists at Sequella, Inc. ( USA ) and the US National Institutes ... ... Maxwell Biotech Venture Fund Logo ...
(Date:3/27/2017)... ... March 27, 2017 , ... PMG Research is pleased ... conference presented by The Conference Forum in Boston on April 3-4, 2017. The CTC ... improved clinical trial outcomes and bring them closer to the patient. Clinical Trial Collaborations ...
(Date:3/27/2017)... , March 27, 2017 Neurotrope, ... novel therapies for neurodegenerative diseases, including Alzheimer,s disease, ... its application to list the Company,s common stock ... by The NASDAQ Stock Market, a unit of ... listing, Neurotrope will ring the Opening Bell at the ...
(Date:3/24/2017)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), ... , today announced that its board of directors has amended its ... from March 27, 2017 to March 27, 2018. The amendment was not ... Biotech Ltd. ... Sinovac Biotech Ltd. is a China -based ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
Breaking Biology News(10 mins):